Abstract B10: Studying BCL-2 dependence using BH3 profiling in a phase 2 clinical trial of ABT-199 in acute myeloid leukemia.
Year: 2015
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: Dana-Farber Cancer Institute, AbbVie (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2336685181
